ARCHIVES

In Brief: Hisserich Named USC Assistant VP, Replaced By Rideout At Cancer Center; DeVita Assures Groups

This article is from The Cancer Letter archive.

Vol. 12 No. 26 | June 27, 1986

Download PDF Visit The Full Archive

Related Articles

PCORI Approves $54.8 Million For Clinical Effectiveness Research

August 1, 2014

Beta Blockers Negate Harmful Recurrence Risks of ACE Inhibitors

April 29, 2011

Varmus, In Letter To Institute Pasteur, Reopens Discussion Of Test Kit Royalties

July 1, 1994

Letter: Biostatistics Directors Invited To Share Concerns

June 7, 1996

President’s Budget Versus NCI’s Bypass: A Comparison

February 21, 1992

Congressional Panel Is Investigating FDA Oversight Of Generic Cancer Drugs

August 18, 1995